Last reviewed · How we verify

NCT07364604

Very Early Outcomes in Endoscopic Versus Open Carpal Tunnel Release

Completed Last updated 23 January 2026
What this trial tests

trial testing Carpal Tunnel Release in Carpal Tunnel Syndrome (CTS) in 113 participants. Completed in 30 June 2024.

Timeline
1 March 2022
Primary endpoint
30 June 2024
30 June 2024

Quick facts

Lead sponsorStanford University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment113
Start date1 March 2022
Primary completion30 June 2024
Estimated completion30 June 2024
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Stanford University

Who can join

18 and older, any sex, with Carpal Tunnel Syndrome (CTS). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

We are looking at whether there is a difference in pain and function in the very early period when comparing carpal tunnel release performed by the endoscopic technique versus the open technique.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Carpal Tunnel Release

Trials testing the same drug.

Other recruiting trials for Carpal Tunnel Syndrome (CTS)

Currently open trials in the same condition.

Other Stanford University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07364604.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing